Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Your Profile Become a Member/Get Newsletter Log In Contact Us
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Search Grants
Updated 6 May 2012
Government  
Sponsor:  
Non-Government  
Sponsor:  
Award:   Min.:     Max.:
Application Deadline:   Jan - Mar    Apr - Jun    Jul - Sep    Oct - Dec
 
Keyword:  
Grants – Most Recently Added and Modified
or
1 to 10 of 10 results Printable version
Program:NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22)
Sponsor(s): National Institute of Neurological Disorders and Stroke (NINDS)
Details: The NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), is designed to increase the number of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research. Individuals from diverse backgrounds underrepresented in neuroscience research are eligible for support under this award if they have doctoral research degrees (Ph.D., P.h.D./M.D. or equivalent) and between 2 and 5 years of postdoctoral research experience at the time of application.
Program:NIH Blueprint for Neuroscience Research Grand Challenge: Discovering Novel Drugs for Disorders of the Nervous System (U01)
Sponsor(s): National Institute of Mental Health (NIMH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Child Health and Human Development (NICHD)
National Institute of Nursing Research (NINR)
National Institute on Aging (NIA)
National Institute of General Medical Sciences (NIGMS)
National Institute of Environmental Health Sciences (NIEHS)
National Center for Complementary and Alternative Medicine (NCCAM)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
Office of Behavioral and Social Sciences Research (OBSSR)
National Eye Institute (NEI)
Details: he National Institutes of Health (NIH) announces a unique opportunity for investigators working with small molecule compounds to gain access to a robust ‘virtual pharma’ network to discover neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug discovery services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to conduct biological testing of compound analogs in disease assays and models in the investigator’s laboratory. No-cost drug discovery services will also be provided, including medicinal chemistry optimization, IND-directed pharmacology and toxicology, and Phase I clinical testing. Researchers in possession of disease assays and small molecule compounds that show promise for treating nervous system and psychiatric disorders, but that are not yet suitable for clinical testing, are strongly encouraged to apply.
Deadline(s): Note Change in Dates! Letter of Intent: September 8, 2012;
Application: October 8, 2012.
Program:Harnessing Advanced Health Technologies to Drive Mental Health Improvement (R01)
Sponsor(s): National Institute of Mental Health (NIMH)
Details: The purpose of this Funding Opportunity Announcement (FOA) is to test the innovative use of existing technologies to significantly improve access to and quality of mental health care, and to propose the collection and use of actionable mental health information to improve outcomes of people with mental disorders. See also FOA of identical scope under R34 grant mechanism.
Deadline(s): Letter of Intent: May 22, 2012;
Application: June 22, 2012.
Program:Mental Health Research Dissertation Grant to Increase Diversity (R36)
Sponsor(s): National Institute of Mental Health (NIMH)
Details: The purpose of this Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), is to increase the diversity of the mental health research workforce by providing dissertation awards in all areas of research within the strategic priorities of the NIMH to individuals from diverse backgrounds underrepresented in mental health research to support the completion of the doctoral research project.
Deadline(s): April 23, August 22, December 21, 2012;
April 22, August 22, December 23, 2013;
April 22, August 22, December 22, 2014.
Program:Grand Challenges in Global Mental Health: Integrating Mental Health into Chronic Disease Care Provision in Low- and Middle-Income Countries (R01)
Sponsor(s): National Institute of Mental Health (NIMH)
Details: This Funding Opportunity Announcement (FOA) seeks research project grant (R01) applications that promote the establishment of an evidence base on contextually relevant, cost-effective integrated care interventions for the treatment of patients with co-morbid mental and chronic physical illnesses in low- and middle-income countries (LMICs). Specifically, this FOA will support research that builds on existing chronic disease care and treatment platforms to incorporate management of mental illness, employs a multi-disease care management approach with potentially high impact for improving patient- and system-level outcomes (e.g., patient morbidity and functioning; improved diagnosis of mental illness among patients with chronic medical illnesses; decreased cost to the health care system; improved care coordination), and establishes feasible methods for multi-disease management in LMICs.
Deadline(s): Letter of Intent Due Date: May 20, 2012; Application Due Date: June 20, 2012.
Program:Development of Tools to Explore the Synaptome (R21)
Sponsor(s): National Institute of Mental Health (NIMH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Child Health and Human Development (NICHD)
National Institute of Nursing Research (NINR)
National Institute on Aging (NIA)
National Institute of General Medical Sciences (NIGMS)
National Institute of Environmental Health Sciences (NIEHS)
National Center for Complementary and Alternative Medicine (NCCAM)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Office of Behavioral and Social Sciences Research (OBSSR)
National Eye Institute (NEI)
Details: This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health, encourages applications that will develop novel technologies and/or tools to facilitate the study of genes and proteins at the synapse on a large scale. Being able to characterize the synaptome in the context of hundreds of genes/proteins would be a major advance for basic and translational research. The technologies/tools created would be expected to affect the fields of neurology, psychiatry, and neuroscience by enriching existing resources as well as those in development. The new tools should enable discovery science related to the synapse by providing for substantially greater sensitivity, selectivity, spatiotemporal resolution and markedly decreased costs compared to currently available technologies.
Deadline(s): Letter of Intent Due Date: March 16, 2012; Application Due Date: April 16, 2012.
Program:MIND Foundation Research Grants
Sponsor(s): MIND Foundation of British Columbia
Details: For studies relevant to advancing our understanding and treatment of addiction, schizophrenia, or combinations of both, the MIND Foundation of BC offers the following research grant opportunities:
  • Two Young Investigator Awards of $50,000 a year for two years. Candidates must have attained the status of Assistant Professor or equivalent in the last six years.
  • One post Doctoral Fellowship Award of $40,000 for one year.
  • Three Research Awards of approximately $20,000 each for one year.
The research must be conducted principally in British Columbia.
Deadline(s): April 30, 2012
Program:Depression and ADHD Fellowships
Sponsor(s): Klingenstein Third Generation Foundation
Details: Investigators must hold a Ph.D. and/or an M.D. degree, and have completed all training, including clinical and/or research training. Candidates should be planning a career in research related to child and adolescent depression or ADHD, and should have demonstrated skills for independent research. The Foundation particularly wishes to support young researchers to complete two-year research projects that could lead to potentially larger projects involving federal funding and/or other national research awards (for example K awards from NIMH). Nominations are invited from institutions; to receive an invitation, contact the foundation (see website).
Deadline(s): Nominations due January 13, 2011; applications due March 25, 2012.
Program:Eppendorf Award for Young European Investigators
Sponsor(s): Eppendorf International
Details: The Eppendorf Award for Young European Investigators is presented to young scientists for outstanding achievements in the field of biomedical research based on methods of molecular biology. The Award is presented in partnership with the scientific journal Nature. Prize money: €15,000
Deadline(s): January 15, 2012
Program:Eppendorf & Science Prize for Neurobiology
Sponsor(s): Eppendorf International
Details: The prize is awarded annually to one young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted by him/her during the past three years.
Deadline(s): June 15, 2012
1 to 10 of 10 results Printable version
SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark

See the first in our new Schizophrenia Bulletin theme section Webinar series: The Extended Psychosis Phenotype.

Check out our recent Webinar titled Cognitive Remediation in Schizophrenia: Ready for Widespread Use?, held 15 December 2011.
Copyright © 2005- 2012 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright